IL107642A0 - Progenitor b cell stimulating factor - Google Patents

Progenitor b cell stimulating factor

Info

Publication number
IL107642A0
IL107642A0 IL10764293A IL10764293A IL107642A0 IL 107642 A0 IL107642 A0 IL 107642A0 IL 10764293 A IL10764293 A IL 10764293A IL 10764293 A IL10764293 A IL 10764293A IL 107642 A0 IL107642 A0 IL 107642A0
Authority
IL
Israel
Prior art keywords
progenitor
stimulating factor
cell stimulating
factor
promotes
Prior art date
Application number
IL10764293A
Other languages
English (en)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of IL107642A0 publication Critical patent/IL107642A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IL10764293A 1992-11-20 1993-11-17 Progenitor b cell stimulating factor IL107642A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98052492A 1992-11-20 1992-11-20

Publications (1)

Publication Number Publication Date
IL107642A0 true IL107642A0 (en) 1994-02-27

Family

ID=25527627

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10764293A IL107642A0 (en) 1992-11-20 1993-11-17 Progenitor b cell stimulating factor

Country Status (15)

Country Link
US (2) US5580754A (fr)
EP (1) EP0601360B1 (fr)
JP (1) JPH08505373A (fr)
KR (1) KR950704356A (fr)
CN (1) CN1094093A (fr)
AT (1) ATE159545T1 (fr)
AU (1) AU680851B2 (fr)
CA (1) CA2149763A1 (fr)
DE (1) DE69314754T2 (fr)
DK (1) DK0601360T3 (fr)
ES (1) ES2108189T3 (fr)
GR (1) GR3025718T3 (fr)
IL (1) IL107642A0 (fr)
MX (1) MX9307229A (fr)
WO (1) WO1994012535A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852508B1 (en) * 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
WO2000062073A1 (fr) * 1999-04-12 2000-10-19 Sumitomo Chemical Company, Limited Procede d'analyse de la quantite de tissu adipeux intra-abdominal
JP4689787B2 (ja) * 1999-04-12 2011-05-25 住友化学株式会社 腹腔内脂肪組織量の分析方法
AUPQ147799A0 (en) * 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
US8062675B2 (en) 1999-07-07 2011-11-22 Angioblast Systems, Inc. Mesenchymal precursor cell
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AU2001271054A1 (en) * 2000-07-31 2002-02-13 Sumitomo Chemical Company Limited Method of analyzing accumulated fat content in adipocytes
US20040033238A1 (en) * 2000-11-10 2004-02-19 Mulks Martha H. Selectable genetic marker for use in pasteurellaceae species
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US7488792B2 (en) * 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
JP2007530417A (ja) * 2003-07-01 2007-11-01 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 細胞及び生物の寿命及びストレス応答を操作するための組成物
US20060025337A1 (en) * 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
US7444419B2 (en) * 2003-10-10 2008-10-28 Microsoft Corporation Media stream scheduling for hiccup-free fast-channel-change in the presence of network chokepoints
JP2007527418A (ja) * 2003-12-29 2007-09-27 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 肥満及びインシュリン耐性障害を治療又は防止するための組成物
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
JP2005213206A (ja) * 2004-01-30 2005-08-11 Iichiro Shimomura 糖代謝機能改善剤
US20060084085A1 (en) * 2004-06-16 2006-04-20 Sinclair David A Methods and compositions for modulating Bax-mediated apoptosis
KR20130100225A (ko) * 2004-09-24 2013-09-09 안지오블라스트 시스템스 인코퍼레이티드 간엽 전구세포의 증식 및/또는 생존성 증강 방법
AU2006204699B2 (en) * 2005-01-13 2012-04-26 Sirtris Pharmaceuticals, Inc. Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
WO2006138418A2 (fr) * 2005-06-14 2006-12-28 President And Fellows Of Harvard College Amelioration de la performance cognitive avec des activateurs de sirtuine
CN100457911C (zh) * 2006-01-24 2009-02-04 中国人民解放军第二军医大学 含有效b细胞活化因子基因启动子的重组质粒及其制备方法和用途
US8506933B2 (en) * 2007-11-30 2013-08-13 Msdx, Inc. Methods of detecting a neurological condition via analysis of circulating phagocytes
US20110129857A1 (en) * 2009-11-27 2011-06-02 Msdx, Inc. Methods Of Detecting Or Monitoring Activity Of An Inflammatory Condition Or Neurodegenerative Condition
MX2011007970A (es) * 2009-02-24 2011-10-19 Healor Ltd Agentes terapeuticos de visfatina para el tratamiento de acne y otras condiciones.
US8673309B2 (en) 2011-02-11 2014-03-18 Msdx, Inc. Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
CN117126756B (zh) * 2023-10-26 2024-03-12 中国科学院天津工业生物技术研究所 一种用于制备烟酰胺磷酸核糖基转移酶的重组菌株的构建方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179937A (en) * 1978-06-02 1979-12-25 Ocean Ecology Ltd. Sound measuring device
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
JPS63500636A (ja) * 1985-08-23 1988-03-10 麒麟麦酒株式会社 多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5066581A (en) * 1987-02-25 1991-11-19 The Trustees Of Columbia University In The City Of New York Differentiation antigen, nda3, associated with the receptor for b cell growth factor
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
WO1989006541A1 (fr) * 1988-01-14 1989-07-27 West Virginia University Sequences d'adn, molecules d'adn recombinant et procedes de production de polypeptides du facteur-1 lymphopoietique derive du stroma
JP2657113B2 (ja) * 1989-10-16 1997-09-24 アムジエン・インコーポレーテツド 幹細胞因子

Also Published As

Publication number Publication date
JPH08505373A (ja) 1996-06-11
AU5613594A (en) 1994-06-22
US5580754A (en) 1996-12-03
CN1094093A (zh) 1994-10-26
MX9307229A (es) 1994-07-29
AU680851B2 (en) 1997-08-14
WO1994012535A1 (fr) 1994-06-09
US5874399A (en) 1999-02-23
ES2108189T3 (es) 1997-12-16
EP0601360A1 (fr) 1994-06-15
ATE159545T1 (de) 1997-11-15
EP0601360B1 (fr) 1997-10-22
DE69314754T2 (de) 1998-02-19
KR950704356A (ko) 1995-11-20
DK0601360T3 (da) 1998-04-20
GR3025718T3 (en) 1998-03-31
DE69314754D1 (de) 1997-11-27
CA2149763A1 (fr) 1994-06-09

Similar Documents

Publication Publication Date Title
IL107642A0 (en) Progenitor b cell stimulating factor
PT85285A (en) Process for producing il-6 and of pharmaceutical compositions containing the same
GB8516421D0 (en) Fibronectins
ATE149524T1 (de) Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung
EG17972A (en) Process for the extraction and purification of proteins from culture media producing them
EP0301541A3 (en) Luciferase gene and novel recombinant dna as well as a method of producing luciferase
ZA917605B (en) Method of introducing foreign dna into cells
AU682140B2 (en) Multidrug resistance gene
DK1396542T3 (da) P-selectin ligand protein
ATE135049T1 (de) Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
DE69313316T2 (de) Verwendung von Oxazopyrrolochinolinen und Pyrrolochinolonchinonen zur Herstellung von Produktionsbeschleunigern von Nervenwachstumsfaktoren g
ATE13910T1 (de) Verfahren zur zuechtung von humanen fibroblasten und fibroblastenartigen zellen.
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
DE3886234D1 (de) DNA-Sequenzen, Plasmide und Mikroorganismen sowie Verfahren zur Herstellung von Chinolinsäure.
HU208658B (en) Biological method for increasing of efficiency of sewage uatercleaning and/or mud-cure
PL253361A1 (en) Pack-type biological sevage treatment plant
AU607129C (en) Human basic fibroblast growth factor (hbFGF) and method of production thereof using genetic engineering techniques
ATE84543T1 (de) Herstellung von hoch-gereingtem menschlichen faktor ix sowie anderem plasmaproteinkonzentrat und dessen therapeutische verwendung.
AU6983087A (en) Human basic fibroblast growth factor (hbFGF) and method of production thereof using genetic engineering techniques
DE3890677T1 (de) Biologische materialien, verfahren zur herstellung biologischer materialien und zur verwendung dieser materialien bei der therapie